Original Research
Published on 04 Oct 2022
Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice
in Infectious Agents and Disease
- 2,173 views
- 2 citations